Recombinant Prosaposin antibody
Quick Overview for Recombinant Prosaposin antibody (ABIN7477571)
Target
See all Prosaposin (PSAP) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Immunogen
- Recombinant full-length human ACPP protein
-
Isotype
- IgG
-
-
-
-
Application Notes
- IHC 1:100-1:200
-
Comment
-
Positive Control: Prostate: A strong PSAP immunostaining should, be seen in all glandular cells.
Negative Control: Appendix: All epithelial and non-epithelial structures must not show any PSAP immunostaining.
-
Protocol
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
-
- Prosaposin (PSAP)
-
Alternative Name
- PSAP
-
Background
- 5'-nucleotidase (5'-NT), Acid phosphatase prostate, ACP3, Ecto-5'-nucleotidase, Prostatic acid phosphatase (PAP), Prostatic acid phosphatase, Thiamine monophosphatase (TMPase),PSAP antibody validated for immunohistochemistry on 76 different Normal Tissues
-
UniProt
- P15309
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-